Another new drug for type 2 diabetes, called Prandin (repaglinide)

March 1998

You'll soon see another new drug for type 2 diabetes, called Prandin (repaglinide).

It's the first of a new class...the meglitinides.

Prandin is given before meals to reduce postprandial hyperglycemia. It stimulates the pancreas to release more insulin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Hear a lot more about homocysteine
Venastat to relieve leg swelling due to varicose veins
Singulair (montelukast) for asthma
Serevent is approved for treating chronic obstructive pulmonary disease (COPD)
Obesity & Weight Loss New obesity drug, Meridia
Cardiology New combination antihypertensive called Teczem
Cardiology Whether patients can still take erythromycin before dental procedures to prevent bacterial endocarditis
Neurology & Pain New oral migraine drug, Amerge
Neurology & Pain Tasmar (tolcapone) for Parkinson's
Women's Health New strength of Prempro
Women's Health Topical testosterone for libido
Gastroenterology PrevPac, a new kit for H. pylori
Diabetes Boxed warning about which patients shouldn't take metformin (Glucophage)
Diabetes Another new drug for type 2 diabetes, called Prandin (repaglinide)
STIs New STD treatment guidelines
Poison Prevention National Poison Prevention Week is this month